Clinical Data Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Clinical Data Inc.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike McFarland who wrote (33)	5/24/2008 3:28:45 PM
From: Mike McFarland	of 39

Big Pharma companies do possess one potentially valuable and proprietary asset to exploit in the new landscape. Each owns a portfolio of small molecule failures – potential drugs with good safety profiles who demonstrated no significant efficacy in phenotype patient samples. Remaining patent protection on these compounds varies but retesting against genotyped trial samples with relevant biomarkers could provide a substantial kick start to entry in the new landscape. deloitte.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next